Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 8.95% | 147.96 | 0.0% | $976.95m | |
| AMGN | Amgen, Inc. | 0.70% | 254.81 | 1.5% | $857.91m | |
| GILD | Gilead Sciences, Inc. | -0.11% | 64.40 | 1.0% | $544.24m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 1.04% | 272.45 | 1.9% | $492.78m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.78% | 688.78 | 2.6% | $437.93m | |
| ILMN | Illumina, Inc. | 5.06% | 255.89 | 3.3% | $329.32m | |
| NVAX | Novavax, Inc. | 18.93% | 55.98 | 75.7% | $307.36m | |
| BIIB | Biogen, Inc. | 0.46% | 205.15 | 1.8% | $233.76m | |
| BNTX | BioNTech SE | 4.92% | 165.93 | 0.0% | $221.36m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | 2.86% | 2.16 | 0.7% | $150.99m | |
| EXAS | EXACT Sciences Corp. | 6.46% | 53.08 | 17.7% | $136.48m | |
| TXG | 10X Genomics, Inc. | 11.94% | 53.01 | 0.0% | $106.48m | |
| TECH | Bio-Techne Corp. | 5.45% | 385.24 | 4.5% | $105.78m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 2.35% | 80.71 | 4.2% | $96.76m | |
| CRSP | CRISPR Therapeutics AG | 4.20% | 57.55 | 0.6% | $83.77m |
Company Profile
Cortexyme, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics. Its pipeline composed of COR388, COR588, COR788, COR822, and Coronavirus 3CL protease inhibitor. The company was founded by Casey Crawford Lynch, Stephen Dominy, and Kristen Gafric on June 20, 2012 and is headquartered in South San Francisco, CA.